MyHealth

Manage your account, request prescriptions, set up appointments & more.

LOG IN
Don't have an account
Contact Us

KRAS MUTATION ANALYSIS BY PCR

Synonym

therascreen® KRAS RGQ PCR, KRAS, therascreen

Includes

Seven somatic mutations in the human KRAS oncogene

Guidelines

therascreen® KRAS RGQ PCR is a companion diagnostic for ERBITUX®.

Specimen Collection Requirements

Collect

Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue. Protect from excessive heat. Transport tissue block or 5 unstained 5-10micron slides. (Min: 3 slides)

Transport

Room Temperature

Rejection Criteria

Specimens fixed/processed in alternative fixatives (alcohol, Prefer®), frozen or decalcified specimens

Stability

Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable

Testing Information

Performed

Weekly

Reported

4-10 days

Method

Real time PCR assay, FDA-approved, Qiagen Therascreen in vitro diagnostics (IVD) kit to detect the major KRAS mutations involving codon 12 and 13. 

Reference Values

Reference Values

No mutation

CPT Codes

81275

Last Updated: Thursday, November 9, 2017 11:04:08 AM


Client Services: 503-413-1234